The association of estimated whole blood viscosity with hemodynamic parameters and prognosis in patients with heart failure

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Yancy CW, Jessup M, Bozkurt B et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 62(16), e147–e239 (2013).
  MedlineGoogle Scholar
• 2 Goldsmith SR, Brandimarte F, Gheorghiade M. Congestion as a therapeutic target in acute heart failure syndromes. Prog. Cardiovasc. Dis. 52(5), 383–392 (2010).
  Medline CASGoogle Scholar
• 3 Katz SD. In search of euvolemia in heart failure. JACC Heart Fail. 2(3), 306–307 (2014).
  MedlineGoogle Scholar
• 4 Tschöpe C, Pieske B. One size does not fit all: how to individualize decongestive therapy strategies in heart failure. JACC Heart Fail. 4(6), 460–463 (2016).
  MedlineGoogle Scholar
• 5 de Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81(1), 107–117 (1990). •• The first study that researchers composed whole blood viscosity equations using total protein and hematocrit level to estimate viscometer derived whole blood viscosity and validated these formulas.
  Medline CASGoogle Scholar
• 6 Baskurt OK, Hardeman MR, Rampling MW. Handbook of Hemorheology and Hemodynamics. IOS Press, DC, USA, 45–71 (2007).
  Google Scholar
• 7 de Simone G, Devereux RB, Chinali M et al. Risk factors for arterial hypertension in adults with initial optimal blood pressure. Hypertension 47(2), 162–167 (2006).
  Medline CASGoogle Scholar
• 8 Fowkes FG, Housley E, Cawood EH, MacIntyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int. J. Epidemiol. 20(2), 384–392 (1991).
  Medline CASGoogle Scholar
• 9 Cetin EHO, Cetin MS, Canpolat U et al. Prognostic significance of whole blood viscosity estimated by de Simone's formula in ST-elevation myocardial infarction. Biomark. Med. 10(5), 495–511 (2016).
  CASGoogle Scholar
• 10 Ergun-Cagli K, Ileri-Gurel E, Ozeke O et al. Blood viscosity changes in slow coronary flow patients. Clin. Hemorheol. Microcirc. 47(1), 27–35 (2011).
  MedlineGoogle Scholar
• 11 Tamariz LJ, Young JH, Pankow JS et al. Blood viscosity and hematocrit as risk factors for Type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am. J. Epidemiol. 168(10), 1153–1160 (2008).
  MedlineGoogle Scholar
• 12 Nwose EU, Richards RS. Whole blood viscosity extrapolation formula: nNote on appropriateness of units. N. Am. J. Med. Sci. 3(8), 384–386 (2011). •• Revises the De Simone equations by using total protein level in the units of (g/l) and hematocrit level (%).
  MedlineGoogle Scholar
• 13 Duarte K, Monnez J-M, Albuisson E, Pitt B, Zannad F, Rossignol P. Prognostic value of estimated plasma volume in heart failure. JACC Heart Fail. 3(11), 886–893 (2015). • One of the important studies demonstrating the prognostic importance of volume status in patients with heart failure.
  MedlineGoogle Scholar
• 14 Lang RM, Badano LP, Mor-Avi V et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 28(1), 1–39 (2015).
  MedlineGoogle Scholar
• 15 Rosenkranz S, Preston IR. Right heart catheterisation: best practice and pitfalls in pulmonary hypertension. Eur. Respir. Rev. 24(138), 642–652 (2015).
  MedlineGoogle Scholar
• 16 Galiè N, Humbert M, Vachiery J-L et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Heart J. 37(1), 67–119 (2016).
  MedlineGoogle Scholar
• 17 Lee AJ, Mowbray PI, Lowe GD, Rumley A, Fowkes FG, Allan PL. Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study. Circulation 97(15), 1467–1473 (1998).
  Medline CASGoogle Scholar
• 18 Lowe GD, Fowkes FG, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 87(6), 1915–1920 (1993).
  Medline CASGoogle Scholar
• 19 Rampling MW. Haemorheological disturbances in hypertension: the influence of diabetes and smoking. Clin. Hemorheol. Microcirc. 21(3-4), 183–187 (1999).
  Medline CASGoogle Scholar
• 20 Sweetnam PM, Thomas HF, Yarnell JWG, Beswick AD, Baker IA, Elwood PC. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease: the Caerphilly and Speedwell Studies. Eur. Heart J. 17(12), 1814–1820 (1996).
  Medline CASGoogle Scholar
• 21 Yarnell JW, Baker IA, Sweetnam PM et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 83(3), 836–844 (1991).
  Medline CASGoogle Scholar
• 22 Peters SA, Woodward M, Rumley A, Tunstall-Pedoe HD, Lowe GDO. Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study. Eur. J. Prev. Cardiol. 24(2), 161–167 (2017).
  MedlineGoogle Scholar
• 23 Androne A-S, Katz SD, Lund L et al. Hemodilution is common in patients with advanced heart failure. Circulation 107(2), 226–229 (2003).
  MedlineGoogle Scholar
• 24 van der Meer P, Postmus D, Ponikowski P et al. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J. Am. Coll. Cardiol. 61(19), 1973–1981 (2013). •• An important study about the hemoconcentration in patients with heart failure.
  Medline CASGoogle Scholar
• 25 Groenveld HF, Januzzi JL, Damman K et al. Anemia and mortality in heart failure patients: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 52(10), 818–827 (2008).
  MedlineGoogle Scholar
• 26 Tang Y-D, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 113(20), 2454–2461 (2006).
  MedlineGoogle Scholar
• 27 Arques S, Ambrosi P. Human serum albumin in the clinical syndrome of heart failure. J. Card. Fail. 17(6), 451–458 (2011).
  Medline CASGoogle Scholar
• 28 Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am. Heart J. 155(5), 883–889 (2008).
  Medline CASGoogle Scholar
• 29 Ling HZ, Flint J, Damgaard M et al. Calculated plasma volume status and prognosis in chronic heart failure. Eur. J. Heart Fail. 17(1), 35–43 (2015).
  Medline CASGoogle Scholar
• 30 Strauss MB, Davis RK, Rosenbaum JD, Rossmeisl EC. Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution. J. Clin. Invest. 30(8), 862–868 (1951).
  Medline CASGoogle Scholar
• 31 Greene SJ, Gheorghiade M, Vaduganathan M et al. Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur. J. Heart Fail. 15(12), 1401–1411 (2013).
  Medline CASGoogle Scholar
• 32 Binanay C, Califf RM, Hasselblad V et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294(13), 1625–1633 (2005).
  MedlineGoogle Scholar
• 33 Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122(3), 265–272 (2010).
  MedlineGoogle Scholar
• 34 Baskurt OK, Yalcin O, Meiselman HJ. Hemorheology and vascular control mechanisms. Clin. Hemorheol. Microcirc. 30(3-4), 169–178 (2004).
  MedlineGoogle Scholar
• 35 Salazar Vázquez BY, Martini J, Chávez Negrete A et al. Cardiovascular benefits in moderate increases of blood and plasma viscosity surpass those associated with lowering viscosity: experimental and clinical evidence. Clin. Hemorheol. Microcirc. 44(2), 75–85 (2010).
  Medline CASGoogle Scholar
• 36 Intaglietta M. Increased blood viscosity: disease, adaptation or treatment? Clin. Hemorheol. Microcirc. 42(4), 305–306 (2009).
  MedlineGoogle Scholar
• 37 Salazar Vázquez BY, Cabrales P, Tsai AG, Intaglietta M. Nonlinear cardiovascular regulation consequent to changes in blood viscosity. Clin. Hemorheol. Microcirc. 49(1-4), 29–36 (2011).
  MedlineGoogle Scholar
• 38 Martini J, Cabrales P, Tsai AG, Intaglietta M. Mechanotransduction and the homeostatic significance of maintaining blood viscosity in hypotension, hypertension and haemorrhage. J. Intern. Med. 259(4), 364–372 (2006).
  Medline CASGoogle Scholar
• 39 Melkumyants AM, Balashov SA. Rapid communication: effect of blood viscocity on arterial flow induced dilator response. Cardiovasc. Res. 24(2), 165–168 (1990).
  Medline CASGoogle Scholar
• 40 Cho YI, Cho DJ, Rosenson RS. Endothelial shear stress and blood viscosity in peripheral arterial disease. Curr. Atheroscler. Rep. 16(4), 404 (2014).
  MedlineGoogle Scholar
• 41 Jung JH, Chae YJ, Lee DH et al. Changes in whole blood viscosity during hemodialysis and mortality in patients with end-stage renal disease. Clin. Hemorheol. Microcirc. 65(3), 285–297 (2017).
  Medline CASGoogle Scholar